why choose us

First received: March 16, 2023

Clinical Trial: Fecobionics in Biofeedback Therapy in Dyssynergia Patients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dyssynergia

Study Type: INTERVENTIONAL


Official Title: Fecobionics to Monitor and Predict Biofeedback Therapy in Dyssynergia Patients

Brief Summary: Constipation affects 12-19% of Americans.Pelvic floor dyssynergia is considered to play an important role in constipation but the underlying mechanisms are not well understood in individual patients.The investigators have developed a novel device named Fecobionics that provide detailed mapping of physiological parameters during defecation.The aim of the study is to use Fecobionics to assess anorectal function in dyssynergia patients and monitor and predict the outcome of the biofeedback therapy.

Read more